Microneedle Flu Vaccine Market, By Product Type, By Vaccine Type, By Flu Type (Influenza A, Influenza B), By Region - Size, Share, Outlook, and Opportunity Analysis, 2023

Description

Drug delivery through the skin using transdermal patches has always been effective against viral infections and influenza. Transdermal drug delivery is primarily efficient through passive drug diffusion followed by drug development of transdermal delivery systems through various mechanisms of action such as iontophoresis and sonophoresis. Moreover, pharmaceutical companies have focused on the development of microneedle vaccines because of their great utility for transdermal delivery of very large ionic and hydrophilic drug molecules. Some microneedles are made of a drug to be delivered to the body but are shaped into a needle so they will penetrate the skin. The microneedles range in size, shape, and function but are all used as an alternative to other delivery methods like the conventional hypodermic needle or other injection apparatus.

Microneedle patches are designed to precisely deliver drugs into the intradermal space, rich in immune cells, and provide a noninvasive and self-applicable vaccination approach, eliminating the need for hypodermic needles and trained medical personnel for vaccine administration.

Market Dynamics

Increasing adoption of organic growth strategies, such as product launches by key players in the market to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in June 2021, Eclipse Foundation, a leading aesthetic and medical manufacturer, announced the launch of its new product MicroPen EVO, which is a medical-grade micro-needling device.

The increasing clinical trials of the microneedle flu vaccine by key players in the market to expand product portfolio is expected to drive the market growth over the forecast period. For instance, in July 2021, Micron Biomedical, Inc., a clinical stage biopharmaceutical company announced that it has begun trialing a microneedle-based measles-rubella vaccine in children.

Key features of the study:

This report provides in-depth analysis of the global microneedle flu vaccine market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global microneedle flu vaccine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study are Sanofi, GC Pharma, Harro Hofliger, CosMED Pharmaceutical Co.Ltd., Micron Biomedical, Inc., LTS Lohmann Therapie-Systeme AG, Micralyne, Inc., Sorrento Therapeutics, Inc., TSRL, Inc., QUADMEDICINE, Raphas Co., Ltd., Cutanos GmbH, 3M, NanoPass, Corium, Inc., BD, FluGen, Inc., MICRODERMICS INC
Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global microneedle flu vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global microneedle flu vaccine market

Detailed Segmentation:

Global Microneedle Flu Vaccine Market, By Product Type:
- Solid Microneedles
- Hollow Microneedles
- Coated Microneedles
- Dissolving Microneedles
Global Microneedle Flu Vaccine Market, By Vaccine :
- Trivalent Flu Vaccine
- Quadrivalent Flu Vaccine
Global Microneedle Flu Vaccine Market By Flu Type:
- Influenza A
  - H1N1
  - H3N2
- Influenza B
Global Microneedle Flu Vaccine Market, By Region:
- North America
  - By Country:
- U.S.
- Canada
- Latin America
  - By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Country/Region:
- South Africa
- Central Africa
- North Africa
Company Profiles
- Sanofi*
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- GC Pharma
- Harro Hofliger
- CosMED Pharmaceutical Co.Ltd.
- Micron Biomedical, Inc.
- LTS Lohmann Therapie-Systeme AG
- Micralyne, Inc.
- Sorrento Therapeutics, Inc.
- TSRL, Inc.
- QUADMEDICINE
- Raphas Co., Ltd.
- Cutanos GmbH
- 3M
- NanoPass
- Corium, Inc.
- BD
- FluGen, Inc.
- MICRODERMICS INC

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI2286

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Vaccine Type
- Market Snapshot, By Flu Type
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
Product Launches
Merger, Acquisition, Collaborations
Regulatory Guideline and Compliances
Key Developments
PEST Analysis
Vaccine Type Landscape
PORTER's Analysis
Pricing Analysis (2021)

4. Global Microneedle Flu Vaccine Market - Impact of Coronavirus (Covid-19) Pandemic

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Microneedle Flu Vaccine Market, By Product Type, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Solid Microneedles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Hollow Microneedles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Coated Microneedles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Dissolving Microneedles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Microneedle Flu Vaccine Market, By Vaccine Type, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Trivalent Flu Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Quadrivalent Flu Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Microneedle Flu Vaccine Market, By Flu Type, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segments Trends
Influenza A
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
H1N1
H3N2
Influenza B
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Microneedle Flu Vaccine Market, By Region, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Flu Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Flu Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Flu Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Flu Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Flu Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Flu Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Vaccine Companies:
- Sanofi*
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- GC Pharma
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Microneedle Companies:
- Harro Hofliger*
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- CosMED Pharmaceutical Co.Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Micron Biomedical, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- LTS Lohmann Therapie-Systeme AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Micralyne, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Sorrento Therapeutics, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- TSRL, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- QUADMEDICINE
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Raphas Co., Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Cutanos GmbH
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- 3M
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- NanoPass
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Corium, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- BD
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- FluGen, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- MICRODERMICS INC
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

10. Section

Research Methodology
About Us

Microneedle Flu Vaccine Market, By Product Type, By Vaccine Type, By Flu Type (Influenza A, Influenza B), By Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030